Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Observer Blinded, Controlled Trial to Evaluate the Safety and Immunogenicity of a New Formulation of Euvichol® (Killed Bivalent Whole Cell Oral Cholera Vaccine Manufactured by EuBiologics Co. Ltd.) in Healthy Individuals

NCT02502331 is registered in ClinicalTrials.gov with International Vaccine Institute as lead sponsor.

NCT NCT02502331
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02502331 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Observer Blinded, Controlled Trial to Evaluate the Safety and Immunogenicity of a New Formulation of Euvichol® (Killed Bivalent Whole Cell Oral Cholera Vaccine Manufactured by EuBiologics Co. Ltd.) in Healthy Individuals
Lead sponsor
International Vaccine Institute
Phase
Phase 3
Overall status
Unknown status
Start date
March 31, 2016
Completion date
August 31, 2016
Enrollment
442 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cholera